Product Details

INDICATIONS AND USAGE --------------------------
In children 6 weeks through 5 years of age (prior to the 6th birthday), Prevnar 13 is indicated for:
• active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F.
• active immunization for the prevention of otitis media caused by S. pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F. No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A.
In children 6 years through 17 years of age (prior to the 18th birthday), Prevnar 13 is indicated for:
• active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F. (1.2)
In adults 18 years of age and older, Prevnar 13 is indicated for:
• active immunization for the prevention of pneumonia and invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F.
Limitations of Prevnar 13 Use and Effectiveness
• Prevnar 13 does not protect against disease caused by S. pneumoniae serotypes that are not in the vaccine.
------------------------ DOSAGE AND ADMINISTRATION -----------------
Children 6 weeks through 5 years: The four-dose immunization series consists of a 0.5 mL intramuscular injection administered at 2, 4, 6, and 12-15 months of age.
Children 6 through 17 years of age: a single dose.
Adults 18 years and older: a single dose.